X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ABBOTT INDIA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ABBOTT INDIA STERLING BIOTECH/
ABBOTT INDIA
 
P/E (TTM) x -1.9 42.3 - View Chart
P/BV x 0.1 10.6 0.7% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 STERLING BIOTECH   ABBOTT INDIA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ABBOTT INDIA
Mar-16
STERLING BIOTECH/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs116,015 0.2%   
Low Rs33,707 0.1%   
Sales per share (Unadj.) Rs26.81,236.9 2.2%  
Earnings per share (Unadj.) Rs-15.0122.2 -12.2%  
Cash flow per share (Unadj.) Rs-5.5129.0 -4.2%  
Dividends per share (Unadj.) Rs035.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs54.9521.2 10.5%  
Shares outstanding (eoy) m267.8721.25 1,260.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.9 6.6%   
Avg P/E ratio x-0.539.8 -1.2%  
P/CF ratio (eoy) x-1.337.7 -3.4%  
Price / Book Value ratio x0.19.3 1.4%  
Dividend payout %028.6 0.0%   
Avg Mkt Cap Rs m1,862103,296 1.8%   
No. of employees `0001.43.0 45.8%   
Total wages/salary Rs m5473,370 16.2%   
Avg. sales/employee Rs Th5,303.38,891.8 59.6%   
Avg. wages/employee Rs Th403.81,140.0 35.4%   
Avg. net profit/employee Rs Th-2,959.0878.3 -336.9%   
INCOME DATA
Net Sales Rs m7,18126,284 27.3%  
Other income Rs m43504 8.4%   
Total revenues Rs m7,22326,789 27.0%   
Gross profit Rs m9473,665 25.8%  
Depreciation Rs m2,543144 1,761.2%   
Interest Rs m4,3778 54,038.3%   
Profit before tax Rs m-5,9314,017 -147.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9241,421 -135.4%   
Profit after tax Rs m-4,0072,596 -154.3%  
Gross profit margin %13.213.9 94.6%  
Effective tax rate %32.435.4 91.7%   
Net profit margin %-55.89.9 -564.9%  
BALANCE SHEET DATA
Current assets Rs m14,33514,446 99.2%   
Current liabilities Rs m49,8094,725 1,054.2%   
Net working cap to sales %-494.037.0 -1,335.7%  
Current ratio x0.33.1 9.4%  
Inventory Days Days40351 784.8%  
Debtors Days Days17120 872.5%  
Net fixed assets Rs m55,4321,113 4,980.9%   
Share capital Rs m268213 126.1%   
"Free" reserves Rs m13,93510,808 128.9%   
Net worth Rs m14,70111,076 132.7%   
Long term debt Rs m9,4780-   
Total assets Rs m73,98816,241 455.6%  
Interest coverage x-0.4497.0 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.11.6 6.0%   
Return on assets %0.516.0 3.1%  
Return on equity %-27.323.4 -116.3%  
Return on capital %-6.436.3 -17.7%  
Exports to sales %25.90.6 4,212.6%   
Imports to sales %0.212.6 1.3%   
Exports (fob) Rs m1,860162 1,150.9%   
Imports (cif) Rs m123,322 0.4%   
Fx inflow Rs m1,860268 694.0%   
Fx outflow Rs m253,927 0.6%   
Net fx Rs m1,835-3,659 -50.1%   
CASH FLOW
From Operations Rs m1,7192,514 68.4%  
From Investments Rs m-3,148-800 393.8%  
From Financial Activity Rs m1,426-803 -177.6%  
Net Cashflow Rs m-3912 -0.4%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 9.9 0.1 9,900.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 17.1 229.8%  
Shareholders   21,482 18,270 117.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   IPCA LABS  SANOFI INDIA  DR. DATSONS LABS  ORCHID PHARMA LTD  NOVARTIS  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Jan 23, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - ELDER PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS